Condition: Type1diabetes · Type2diabetes · Pre Diabetes · Sponsor: Azienda Ospedaliero-Universitaria di Parma
The goals of this project are to build an experimental tool to dissect out in vivo pancreatic beta cell mass (BCM) and beta cell function (BCF) and to assess for the first time these two determinants of beta cell functional mass (BCFxM) in obesity and in various stages of type 1 and type 2 diabetes mellitus.
This description comes directly from the study's public registry record.
Riccardo Bonadonna, MD · +390521033307 · riccardo.bonadonna@unipr.it
Always discuss trial participation with your own doctor first.
| Azienda Ospedaliero Universitaria di Parma | Parma, Pr, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05662189